To unlock the proteome, scale matters.
Introducing the first large-scale, single-molecule platform designed to comprehensively quantify the proteome.
Changing the scale of what’s possible…
Nautilus Biotechnology seeks to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. By integrating breakthrough innovations in computer science, engineering, and biochemistry, we are developing a large-scale, single-molecule proteomic analysis technology that aims to deliver extreme sensitivity and scale.
By enabling an expansion of both the depth and breadth of proteomic studies, Nautilus’ technology has the potential to revolutionize how biological research is conducted, drugs are identified and developed, and human disease is treated.
To understand the extraordinary complexity of the ever-changing proteome, we are developing a large scale, single-molecule Proteomic Analysis Platform that aims to deliver the speed, simplicity, accuracy and versatility we believe is necessary to set new expectations and change the scale of what’s possible.